Clinical and Experimental Vaccine Research
| 短名 | Clin Exp Vaccine Res |
| Journal Impact | 2.10 |
| 国际分区 | IMMUNOLOGY(Q4) |
| ISSN | 2287-3651, 2287-366X |
| h-index | 19 |
Clin Exp Vaccine Res, the official English journal of the Korean Vaccine Society, is an international, peer reviewed, and open-access journal. It covers all areas related to vaccines and vaccination. Clin Exp Vaccine Res publishes editorials, review articles, special articles, original articles, case reports, brief communications, and correspondences covering a wide range of clinical and experimental subjects including vaccines and vaccination for human and animals against infectious diseases caused by viruses, bacteria, parasites and tumor. The scope of the journal is to disseminate information that may contribute to elaborate vaccine development and vaccination strategies targeting infectious diseases and tumors in human and animals. Relevant topics range from experimental approaches to (pre)clinical trials for the vaccine research based on, but not limited to, basic laboratory, translational, and (pre)clinical investigations, epidemiology of infectious diseases and progression of all aspects in the health related issues. It is published printed and open accessed online issues (https://ecevr.org) two times per year in 31 January and 31 July. Clin Exp Vaccine Res is linked to many international databases and is made freely available to institutions and individuals worldwide
期刊主页| 涉及主题 | 医学生物免疫学病毒学遗传学病理内科学抗体接种疫苗免疫系统抗原化学病毒生物化学基因免疫疾病 |
| 出版信息 | 出版商: Korean Vaccine Society，出版周期: ，期刊类型: journal |
| 基本数据 | 创刊年份: 2017，原创研究文献占比: 88.57%，自引率:4.80%， Gold OA占比: 100.00% |
| 平均审稿周期 | 网友分享经验：8 Weeks |
期刊引文格式
这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Humanized mouse model for vaccine evaluation: an overview
2024-1-1
Effectiveness of BBV152 vaccine and ChAdOx1-S vaccine in preventing severe disease among vaccinated patients admitted to a designated COVID-19 hospital in India
2024-1-1
Safety assessments of recombinant DTaP vaccines developed in South Korea
2024-1-1
Inferring B-cell derived T-cell receptor induced multi-epitope-based vaccine candidate against enterovirus 71: a reverse vaccinology approach
2024-1-1
Immunogenicity of a novel inactivated canine adenovirus type 2 variant vaccine for dogs
2024-1-1
Development and validation of enzyme-linked immunosorbent assay for anti-mouse pertussis immunoglobulin G using international reference anti-<i>Bordetella pertussis</i> mouse serum NIBSC 97/642
2024-1-1
The influence of Omicron on vaccine efficacy and durability: a neurology perspective
2024-1-1
Insights into structural vaccinology harnessed for universal coronavirus vaccine development
2024-1-1
Immunoinformatics studies and design of a novel multi-epitope peptide vaccine against <i>Toxoplasma gondii</i> based on calcium-dependent protein kinases antigens through an <i>in-silico</i> analysis
2024-1-1
A case of alopecia areata after rabies vaccination: unreported adverse effect?
2024-1-1
A narrative review of genomic characteristics, serotype, immunogenicity, and vaccine development of <i>Streptococcus pneumoniae</i> capsular polysaccharide
2024-1-1
Henoch-Schönlein purpura following mRNA COVID-19 vaccination: a case report
2024-1-1
Analysis of physical and biological delivery systems for DNA cancer vaccines and their translation to clinical development
2024-1-1
Urinary incontinence after COVID-19 vaccination: a case study in an 8-year-old boy
2024-1-1
The BCG vaccine, advantages, and disadvantages of introducing new generation vaccines against <i>Mycobacterium tuberculosis</i>
2024-1-1
Intranasal and intraperitoneal immunization against <i>Brucella</i> infection using niosome and mannosylated niosomes containing <i>Brucella</i> recombinant trigger factor/Bp26/Omp31 chimeric protein in a mouse model
2024-1-1
Acute interstitial nephritis with acute kidney injury after COVID-19 vaccination: a case report
2024-1-1
Current development of therapeutic vaccines for the treatment of chronic infectious diseases
2024-1-1
Immune modulation and possible pathological implications mediated by naturally produced immunoglobulin G idiotypes: from historical to recent experimental and clinical studies focused on atopic dermatitis
2024-1-1
Comparative analysis of antibody responses to BNT162b2, ChAdOx1, and CoronaVac vaccines in the Albanian population over the pandemic years 2021 to 2022
2024-1-1
Vaccinomics and adversomics: key elements for a personalized vaccinology
2024-1-1
Evaluating the knowledge, attitude, perception, and readiness of caregivers of under 5-year-old children to accept malaria vaccine in Nigeria
2024-1-1
SARS-CoV-2 parental vaccination and risk of multisystem inflammatory syndrome in children: a single-center retrospective study
2024-1-1
Incidence of narcolepsy symptoms after taking COVID-19 vaccines: a Jordanian cross-sectional study
2024-1-1
Safety and immunogenicity of different booster vaccination schemes for COVID-19 used in El Salvador
2024-1-1
Efficacy, immunogenicity, and safety of COVID-19 vaccines in individuals with liver cirrhosis: a rapid review and meta-analysis
2024-1-1
Acute abdomen following COVID-19 vaccination: a systematic review
2024-1-1
Monitoring and evaluation of provincial classical swine fever immunization implementation with an E2 subunit vaccine in Jeju Island, South Korea
2024-1-1
Humoral immune response to SARS-CoV-2 mRNA vaccines is associated with choice of vaccine and systemic adverse reactions DMD TNR
2023-1-1
Perspective vaccines for emerging viral diseases in farm animals
2023-1-1
Vaccine hesitancy: acceptance of COVID-19 vaccine in Pakistan
2023-1-1
Exploring the underlying factors of COVID-19 vaccination hesitancy in Ahvaz, Iran: a comprehensive cross-sectional study
2023-1-1
Changes in SARS-CoV-2 antibody titers 6 months after the booster dose of BNT162b2 COVID-19 vaccine among health care workers
2023-1-1
Antibody response to COVID-19 vaccination in patients on chronic hemodialysis
2023-1-1
Is SARS-CoV-2 vaccination related Guillain-Barré syndrome really different from that due to other causes?
2023-1-1
Barriers to measles mumps rubella vaccine acceptance in the three southern border provinces of Thailand
2023-1-1
Lassa fever vaccine prospects: identifying immunodominant multi-epitopes as vaccine candidate
2023-1-1
Serological response 5 months after the BNT162b2 COVID-19 vaccination in patients with various hematological disorders in Japan
2023-1-1
Immunogenic characterization of AlPO<sub>4</sub> adsorbed Td vaccine and liposome-mediated Td vaccine
2023-1-1
Exploring the essential need for developing COVID-19 vaccines in the Philippines
2023-1-1
Impact of the COVID-19 vaccine booster strategy on vaccine protection: a pilot study of a military hospital in Taiwan
2023-1-1
Disseminated life-threatening viral skin rash in a child with atopic dermatitis
2023-1-1
COVID-19 vaccine-induced immune thrombotic thrombocytopenia: a review
2023-1-1
Comparison of media for a human peripheral blood mononuclear cell-based <i>in vitro</i> vaccine evaluation system
2023-1-1
Detection of immunity in sheep following anti-rabies vaccination
2023-1-1
Experimental animal models for development of human enterovirus vaccine
2023-1-1
Individual expression and processing of hepatitis C virus E1/E2 epitopes-based DNA vaccine candidate in healthy humans’ peripheral blood mononuclear cells
2023-1-1
The issue of vaccine refusal: the study of a risky behavior
2023-1-1
Strategic construction of mRNA vaccine derived from conserved and experimentally validated epitopes of avian influenza type A virus: a reverse vaccinology approach
2023-1-1
Nondaily dosing schedule of allergen-specific sublingual immunotherapy: efficacy and safety
2023-1-1
帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理
投稿经验分享
分享我的经验，帮你走得更远